NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 239 filers reported holding NEKTAR THERAPEUTICS in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $39,000 | -30.4% | 10,000 | 0.0% | 0.02% | -23.1% |
| Q1 2022 | $56,000 | -54.8% | 10,000 | 0.0% | 0.03% | -53.6% |
| Q4 2021 | $124,000 | -27.1% | 10,000 | 0.0% | 0.06% | -37.8% |
| Q3 2021 | $170,000 | +1.2% | 10,000 | 0.0% | 0.09% | +15.4% |
| Q2 2021 | $168,000 | -10.2% | 10,000 | 0.0% | 0.08% | -17.0% |
| Q1 2021 | $187,000 | 0.0% | 10,000 | 0.0% | 0.09% | -16.8% |
| Q4 2020 | $187,000 | -1.6% | 10,000 | -9.1% | 0.11% | -8.1% |
| Q3 2020 | $190,000 | -28.6% | 11,000 | 0.0% | 0.12% | +0.8% |
| Q2 2020 | $266,000 | +41.5% | 11,000 | +10.0% | 0.12% | +25.8% |
| Q1 2020 | $188,000 | -13.8% | 10,000 | 0.0% | 0.10% | 0.0% |
| Q4 2019 | $218,000 | +19.8% | 10,000 | 0.0% | 0.10% | -39.8% |
| Q3 2019 | $182,000 | – | 10,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |